Steven Mintz, Director at Serina Therapeutics, Inc. (SER), bought 8,943 shares at $6.59 ($59K) on 2024-08-15, disclosed to the SEC on 2024-08-19.
Open-market purchase of $59k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.59 | 1,350 | $9K | 15.1% |
| 2 | $6.59 | 1,543 | $10K | 17.3% |
| 3 | $6.59 | 1,600 | $11K | 17.9% |
| 4 | $6.59 | 1,800 | $12K | 20.1% |
| 5 | $6.59 | 2,650 | $17K | 29.6% |
| Total | $6.59 avg | 8,943 |
| $59K |
| 100% |
| Filing → |
| SER | BUY | 2024-05-23 | $121K | — | Filing → |